Search

everythinglearnresearchcommunity

for

Search:↓

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

COVID-19 and its vaccines can cause various skin issues, with urticaria being the most common.

COVID-19 can cause temporary hair loss.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Insulin resistance linked to obesity may increase COVID-19 severity.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

People who had severe COVID-19 are more likely to experience hair loss.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Forensic medicine is crucial for justice and needs continuous innovation and technology integration.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Low-level laser therapy is a safe, painless method that effectively treats acne and improves skin without post-treatment care.

Quarantine increased hair fall, especially in young women, with no direct link to short sun exposure.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

The alexandrite laser effectively reduces unwanted hair by about 75%.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.